WO2001016291A3 - 07cg27 gene - Google Patents

07cg27 gene Download PDF

Info

Publication number
WO2001016291A3
WO2001016291A3 PCT/US2000/023291 US0023291W WO0116291A3 WO 2001016291 A3 WO2001016291 A3 WO 2001016291A3 US 0023291 W US0023291 W US 0023291W WO 0116291 A3 WO0116291 A3 WO 0116291A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
marker
identified
prostate cancer
human gene
Prior art date
Application number
PCT/US2000/023291
Other languages
French (fr)
Other versions
WO2001016291A2 (en
Inventor
Sean V Tavtigian
Brad Swedlund
Jacques Simard
Johanna M Rommens
Original Assignee
Myriad Genetics Inc
Hospital For Sick Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc, Hospital For Sick Children filed Critical Myriad Genetics Inc
Priority to AU70709/00A priority Critical patent/AU7070900A/en
Publication of WO2001016291A2 publication Critical patent/WO2001016291A2/en
Publication of WO2001016291A3 publication Critical patent/WO2001016291A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

A human gene which is here named 07CG27 has been identified which is a marker for prostate cancer.
PCT/US2000/023291 1999-08-27 2000-08-25 07cg27 gene WO2001016291A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU70709/00A AU7070900A (en) 1999-08-27 2000-08-25 07cg27 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15104999P 1999-08-27 1999-08-27
US60/151,049 1999-08-27

Publications (2)

Publication Number Publication Date
WO2001016291A2 WO2001016291A2 (en) 2001-03-08
WO2001016291A3 true WO2001016291A3 (en) 2001-07-26

Family

ID=22537122

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/023291 WO2001016291A2 (en) 1999-08-27 2000-08-25 07cg27 gene

Country Status (2)

Country Link
AU (1) AU7070900A (en)
WO (1) WO2001016291A2 (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "ESP yeast protein expression and purification system", 1997, STRATAGENE 1997/1998 CATALOG, XP002935290 *
CAPECCHI M.R.: "Targeted gene replacement", SCIENTIFIC AMERICAN, March 1994 (1994-03-01), pages 34 - 41, XP002935291 *
DATABASE GENBANK [online] 19 July 1999 (1999-07-19), RHODES ET AL.: "Novel human mRNA from chromosome 1, which has similarities to BAT2 genes", XP002935289, Database accession no. AL096857 *
THEILER KARL: "The house mouse", 1989, SPRINGER-VERLAG, NEW YORK, XP002935292 *

Also Published As

Publication number Publication date
WO2001016291A2 (en) 2001-03-08
AU7070900A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
AU2001292802A1 (en) Genetic markers for tumors
AU2002361908A1 (en) Methods for identifying marker genes for cancer
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2002351828A1 (en) Novel genetic markers for leukemias
AU2002362454A1 (en) Regulated breast cancer genes
AU2001251348A1 (en) Apparatus for sensing human prostate tumor
AU3546400A (en) Tandem immuno-assay for cancer
AU2001296936A1 (en) Brachytherapy seed deployment system
AU2001233626A1 (en) Marker
AU2002335640A1 (en) Gleason grade 4/5 prostate cancer genes
AUPQ923100A0 (en) Treatment of prostate cancer
WO2002059368A8 (en) Specific mucin expression as a marker for pancreatic cancer
AU2001270082A1 (en) Gene markers for lung cancer
AU2002360345A1 (en) Prostate cancer genes
AU2003204331A1 (en) Gene Encoding Labyrinthin, A Marker For Cancer
HK1033151A1 (en) Gene encoding labyrinthin, a marker for cancer
AU2001229461A1 (en) Method for inhibiting a tumor
AU2003214944A1 (en) Secreted caveolin as a marker for prostate cancer
AU2001282175A1 (en) An organic mineral fertilizer
AU2001282149A1 (en) Improved marker
EP1208232A4 (en) Markers for prostate cancer
WO2001016291A3 (en) 07cg27 gene
AU2001231192A1 (en) Mob-5/hmob-5 as a cancer diagnostic marker
AU2003280693A1 (en) Prostate cancer tumor marker
AU6017900A (en) Novel tumor suppressor gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP